Alzheimer’s is a progressive neurological disease that causes brain cells to shrink and die. It is characterized by memory problems, visual-spatial issues and impaired judgment. The Centers for Disease Control and Prevention (CDC) estimates that around 5.8 million Americans have Alzheimer’s disease and similar dementias. Although there is no cure for Alzheimer’s disease, early diagnosis of the neurological condition can allow for treatment and a better quality of life.
Researchers have long theorized that eyes, specifically the retina, can…
NOTE TO INVESTORS: The latest news and updates relating to Silo Pharma Inc. (OTCQB: SILOD) are available in the company’s newsroom at https://ibn.fm/SILO
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.